NSE - Delayed Quote INR

Aurobindo Pharma Limited (AUROPHARMA.NS)

1,170.90
+9.80
+(0.84%)
At close: June 10 at 3:29:56 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Assets
497,849,700
450,715,100
398,899,900
339,217,200
Total Liabilities Net Minority Interest
171,380,400
152,207,100
130,381,400
93,476,700
Total Equity Gross Minority Interest
326,469,300
298,508,000
268,518,500
245,740,500
Total Capitalization
342,149,700
319,777,000
274,588,100
248,251,900
Common Stock Equity
326,533,200
298,428,000
268,398,500
245,759,800
Capital Lease Obligations
3,211,900
3,324,100
4,246,900
4,785,000
Net Tangible Assets
284,146,000
257,661,900
229,179,300
209,626,900
Working Capital
124,801,200
120,065,000
100,518,900
99,667,100
Invested Capital
405,950,000
361,580,200
317,013,700
273,764,400
Tangible Book Value
284,146,000
257,661,900
229,179,300
209,626,900
Total Debt
82,628,700
66,476,300
52,862,100
32,789,600
Net Debt
23,727,300
29,217,400
4,652,300
--
Share Issued
580,801.62
585,938.61
585,938.61
585,938.61
Ordinary Shares Number
580,801.62
585,938.61
585,938.61
585,938.61
3/31/2022 - 1/15/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers